Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ovarian Neoplasms

  Free Subscription

Articles published in
Histopathology
    September 2022
  1. BENNETT JA, Oliva E
    The complex and often confusing history, histology and histogenesis of mesonephric, STK11 adnexal tumour and mesonephric-like neoplasms of the upper female genital tract (including broad ligament).
    Histopathology. 2022;81:280-296.
    >> Share

    July 2022
  2. KIHARA A, Amano Y, Fukushima N, Fujiwara H, et al
    ZEB1 expression is frequently detected in undifferentiated and de-differentiated carcinomas, but is not specific among endometrial carcinomas.
    Histopathology. 2022;81:108-118.
    >> Share

  3. TESSIER-CLOUTIER B, Kang EY, Alex D, Stewart CJR, et al
    Endometrial neuroendocrine carcinoma and undifferentiated carcinoma are distinct entities with overlap in neuroendocrine marker expression.
    Histopathology. 2022;81:44-54.
    >> Share

    June 2022
  4. AOUN BA, Skala SL
    Utility of p63 and PTEN staining in distinguishing cervical microglandular hyperplasia from endometrial endometrioid carcinoma with microglandular/mucinous features.
    Histopathology. 2022;80:1102-1111.
    >> Share

    May 2022
  5. PARRA-HERRAN C, McCluggage WG
    Ovarian microcystic stromal tumour: from morphological observations to syndromic associations.
    Histopathology. 2022;80:898-904.
    >> Share

    January 2022
  6. DEVINS KM, Young RH, Watkins JC
    Sclerosing stromal tumour: a clinicopathological study of 100 cases of a distinctive benign ovarian stromal tumour typically occurring in the young.
    Histopathology. 2022;80:360-368.
    >> Share

  7. RAJENDRAN S, McCluggage WG
    Tubo-ovarian high-grade serous carcinomas commonly express CA19.9.
    Histopathology. 2022;80:449-450.
    >> Share

  8. MUNDADA A, Kakkar A, Menon S
    Paratesticular endometrioid adenocarcinoma of the ovarian surface epithelial type with neuroendocrine differentiation: an undescribed entity.
    Histopathology. 2022;80:443-445.
    >> Share

  9. TALIA KL, Parra-Herran C, McCluggage WG
    Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach.
    Histopathology. 2022;80:255-278.
    >> Share

    December 2021
  10. LIN LH, Zamuco RD, Shukla PS
    Intratumoral budding is associated with poor clinical outcome in early-stage clear cell carcinoma of ovary.
    Histopathology. 2021;79:1018-1029.
    >> Share

    November 2021
  11. LIN SY, Wang YH, Hsu CY, Chen YJ, et al
    Analytical validation of human epidermal growth factor receptor 2 immunohistochemistry by the use of the A0485 antibody versus the 4B5 antibody and breast versus gastric scoring guidelines in ovarian clear cell carcinoma.
    Histopathology. 2021;79:758-767.
    >> Share

  12. HACHISUGA K, Ohishi Y, Tomonobe H, Yahata H, et al
    Endometrial endometrioid carcinoma, grade 1, is more aggressive in the elderly than in the young.
    Histopathology. 2021;79:708-719.
    >> Share

    July 2021
  13. WORRELL HI, Sciallis AP, Skala SL
    Patterns of SATB2 and p16 reactivity aid in the distinction of atypical polypoid adenomyoma from myoinvasive endometrioid carcinoma and benign adenomyomatous polyp on endometrial sampling.
    Histopathology. 2021;79:96-105.
    >> Share

    March 2021
  14. KOMMOSS FKF, Cheasley D, Wakefield MJ, Scott CL, et al
    Primary mucinous ovarian neoplasms rarely show germ cell histogenesis.
    Histopathology. 2021;78:640-642.
    >> Share

    February 2021
  15. BEN-MUSSA A, McCluggage WG
    Ovarian seromucinous cystadenomas and adenofibromas: first report of a case series.
    Histopathology. 2021;78:445-452.
    >> Share

    July 2020
  16. BUSCA A, Nofech-Mozes S, Olkhov-Mitsel E, Gien LT, et al
    Histological grading of ovarian mucinous carcinoma - an outcome-based analysis of traditional and novel systems.
    Histopathology. 2020;77:26-34.
    >> Share

    January 2020
  17. MCCLUGGAGE WG
    Endometriosis-related pathology: a discussion of selected uncommon benign, premalignant and malignant lesions.
    Histopathology. 2020;76:76-92.
    >> Share

  18. VERMIJ L, Smit V, Nout R, Bosse T, et al
    Incorporation of molecular characteristics into endometrial cancer management.
    Histopathology. 2020;76:52-63.
    >> Share

  19. WILLIAMS AT, Ganesan R
    Role of the pathologist in assessing response to treatment of ovarian and endometrial cancers.
    Histopathology. 2020;76:93-101.
    >> Share

  20. BERNEY DM, Stoneham S, Arora R, Shamash J, et al
    Ovarian germ cell tumour classification: views from the testis.
    Histopathology. 2020;76:25-36.
    >> Share

  21. EUSCHER ED, Malpica A
    Gynaecological malignancies and sentinel lymph node mapping: an update.
    Histopathology. 2020;76:139-150.
    >> Share

  22. RABBAN JT, Karnezis AN, Devine WP
    Practical roles for molecular diagnostic testing in ovarian adult granulosa cell tumour, Sertoli-Leydig cell tumour, microcystic stromal tumour and their mimics.
    Histopathology. 2020;76:11-24.
    >> Share

  23. CASEY L, Singh N
    Metastases to the ovary arising from endometrial, cervical and fallopian tube cancer: recent advances.
    Histopathology. 2020;76:37-51.
    >> Share

    July 2019
  24. PETERS EEM, Bartosch C, McCluggage WG, Genestie C, et al
    Reproducibility of lymphovascular space invasion (LVSI) assessment in endometrial cancer.
    Histopathology. 2019;75:128-136.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016